1. (1992) Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigattors. N Engl J Med 327:685–691. doi: 10.1056/NEJM199209033271003
2. Balion C, Santaguida PL, Hill S, Worster A, McQueen M, Oremus M, McKelvie R, Booker L, Fagbemi J, Reichert S, Raina P (2006) Testing for BNP and NT-proBNP in the diagnosis and prognosis of heart failure. AHRQ, Rockville. AHRQ Publication No. 06-E014
3. Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG et al (2009) 2009 focused update: ACCF/AHA Guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circ Cardiovasc Qual Outcomes 119:1977–2016. doi: 10.1161/CIRCULATIONAHA.109.192064
4. McKelvie RS, Moe GW, Ezekowitz JA, Heckman GA, Costigan J, Ducharme A et al (2013) The 2012 Canadian Cardiovascular Society heart failure management guidelines update: focus on acute and chronic heart failure. Can J Cardiol 29:168–181. doi: 10.1016/j.cjca.2012.10.007
5. Scottish Intercollegiate Guidelines Network (SIGN) (2007) Management of chronic heart failure. 95. http://www.sign.ac.uk/guidelines/fulltext/95/index.html